Maia H Harris
September 16, 2024 | Law.com
Federal Circuit Decision Clarifies Obviousness-Type Double Patenting and Patent Term Adjustments In 'Allergan v. MSN Laboratories'On August 13, the Federal Circuit issued a precedential ruling that reversed the District of Delaware's application of the Federal Circuit precedent in In re: Cellect to invalidate a claim in an earlier-filed parent application over admittedly patentably indistinct claims in later-filed (and earlier-expired) child patents. This decision has resolved some substantial questions about the application of obviousness-type double patenting that had been raised by last year's In re Cellect decision.
By Maia H. Harris and Emma C. Mann
7 minute read
Trending Stories
- 1Top 10 Predicted Business and Human Rights Issues for 2025
- 2$7.5M in Punitive Damages Awarded in Product Liability Case
- 3Does My Company Really Need a Generative AI Policy?
- 4'This Is a Watershed Moment': Daniel's Law Overcomes Major Hurdle
- 5Navigating the Storm: Effective Crisis Management (Part 1)
More from ALM
- Legal Speak at General Counsel Conference East 2024: Match Group's Katie Dugan & Herrick's Carol Goodman 1 minute read
- Legal Speak at General Counsel Conference East 2024: Eric Wall, Executive VP, Syllo 1 minute read
- Legal Speak at General Counsel Conference East 2024: Virginia Griffith, Director of Business Development at OutsideGC 1 minute read